These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6614689)

  • 41. Recovery after copper-deficiency myeloneuropathy in Wilson's disease.
    Teodoro T; Neutel D; Lobo P; Geraldo AF; Conceição I; Rosa MM; Albuquerque L; Ferreira JJ
    J Neurol; 2013 Jul; 260(7):1917-8. PubMed ID: 23712800
    [No Abstract]   [Full Text] [Related]  

  • 42. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
    Jacquelet E; Poujois A; Pheulpin MC; Demain A; Tinant N; Gastellier N; Woimant F
    J Inherit Metab Dis; 2021 Nov; 44(6):1481-1488. PubMed ID: 34480375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens.
    Hill GM; Brewer GJ; Prasad AS; Hydrick CR; Hartmann DE
    Hepatology; 1987; 7(3):522-8. PubMed ID: 3570163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Wilson's disease with zinc.
    Brewer GJ
    J Lab Clin Med; 1999 Sep; 134(3):322-4. PubMed ID: 10482318
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M; Percl M; Jadresin O; Kolacek S
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some therapeutic observations in Wilson's disease.
    Shoulson I; Goldblatt D; Plassche W; Wilson G
    Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
    [No Abstract]   [Full Text] [Related]  

  • 53. Wilson's disease and copper metabolism--a review.
    Manghani DK; Dastur DK
    Indian J Gastroenterol; 1985 Apr; 4(2):91-3. PubMed ID: 3886537
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
    Walshe JM
    Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penicillamine hepatotoxicity in the treatment of Wilson's disease.
    Menara M; Zancan L; Sturniolo GC
    J Pediatr Gastroenterol Nutr; 1992 Apr; 14(3):353-4. PubMed ID: 1619543
    [No Abstract]   [Full Text] [Related]  

  • 56. [A study of trientine therapy in Wilson's disease with neurological symptoms].
    Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
    No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Copper toxicity, rats and Wilson's disease.
    Nutr Rev; 1975 Feb; 33(2):51-3. PubMed ID: 1124157
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnosis and treatment of presymptomatic Wilson's disease.
    Walshe JM
    Lancet; 1988 Aug; 2(8608):435-7. PubMed ID: 2900362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of Wilson's disease].
    Hoogenraad TU; van Hattum J
    Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.